Notably, immunofluorescence staining results showed that the combination therapy of TACE and RLX can inhibit the expression of Tumor-associated fibroblasts (TAF) activation related proteins α-SMA compared with TACE alone (p < 0.001) (Fig. 5A, E). Here, ACTA1 is linked to neoplasm.